2-(3,4-Dichlorophenyl)-1-[(4aSR,8SR,8aSR)-4-methyl-8-(pyrrolidin-1-yl)-3,4,4a,5,6,7,8,8a-octahydroquinoxalin-1(2H)-yl]ethan-1-one

ID: ALA4462000

PubChem CID: 155529017

Max Phase: Preclinical

Molecular Formula: C21H29Cl2N3O

Molecular Weight: 410.39

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)[C@H]2[C@@H]1CCC[C@@H]2N1CCCC1

Standard InChI:  InChI=1S/C21H29Cl2N3O/c1-24-11-12-26(20(27)14-15-7-8-16(22)17(23)13-15)21-18(24)5-4-6-19(21)25-9-2-3-10-25/h7-8,13,18-19,21H,2-6,9-12,14H2,1H3/t18-,19-,21-/m0/s1

Standard InChI Key:  CQXHKVAZLJKFTQ-ZJOUEHCJSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   15.8554  -15.3123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5208  -15.7866    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1788  -15.3018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9188  -14.5244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1025  -14.5347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5415  -18.4611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2467  -18.0566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2467  -17.2394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5415  -16.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8362  -18.0566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8362  -17.2394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1324  -16.8331    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4241  -17.2394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4241  -18.0566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1324  -18.4675    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.1335  -16.0159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1335  -19.2847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4264  -15.6063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8418  -15.6083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.4275  -14.7891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1363  -14.3829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1378  -13.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4301  -13.1561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7195  -13.5681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7215  -14.3832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0109  -13.1610    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   14.4302  -12.3389    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.8320  -18.8738    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   15.8320  -16.4222    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
 11  9  1  0
 10  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10 11  1  0
 10 15  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 12 16  1  0
 15 17  1  0
 16 18  1  0
  9  2  1  1
 16 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 24 26  1  0
 23 27  1  0
 10 28  1  1
 11 29  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4462000

    ---

Associated Targets(Human)

OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oprd1 Delta opioid receptor (3911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Mu opioid receptor (3620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Kappa opioid receptor (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Sigma-1 receptor (3326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tmem97 Sigma intracellular receptor 2 (922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 410.39Molecular Weight (Monoisotopic): 409.1688AlogP: 3.70#Rotatable Bonds: 3
Polar Surface Area: 26.79Molecular Species: BASEHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.44CX LogP: 3.76CX LogD: 1.72
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: -0.57

References

1. Tangherlini G, Kalinin DV, Schepmann D, Che T, Mykicki N, Ständer S, Loser K, Wünsch B..  (2019)  Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation.,  62  (2): [PMID:30543421] [10.1021/acs.jmedchem.8b01609]

Source